Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232.
Department of Chemistry, Vanderbilt University, Nashville, TN 37232.
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6652-E6659. doi: 10.1073/pnas.1700469114. Epub 2017 Jul 24.
Gram-positive bacteria cause the majority of skin and soft tissue infections (SSTIs), resulting in the most common reason for clinic visits in the United States. Recently, it was discovered that Gram-positive pathogens use a unique heme biosynthesis pathway, which implicates this pathway as a target for development of antibacterial therapies. We report here the identification of a small-molecule activator of coproporphyrinogen oxidase (CgoX) from Gram-positive bacteria, an enzyme essential for heme biosynthesis. Activation of CgoX induces accumulation of coproporphyrin III and leads to photosensitization of Gram-positive pathogens. In combination with light, CgoX activation reduces bacterial burden in murine models of SSTI. Thus, small-molecule activation of CgoX represents an effective strategy for the development of light-based antimicrobial therapies.
革兰氏阳性菌引起了大多数皮肤和软组织感染(SSTIs),是导致 美国最常见的就诊原因。最近,人们发现革兰氏阳性病原体使用了一种独特的血红素生物合成途径,这表明该途径是开发抗菌治疗方法的一个靶点。我们在这里报告了从革兰氏阳性菌中鉴定出一种小分子细胞色素 c 氧化酶(CgoX)激活剂,该酶是血红素生物合成所必需的。CgoX 的激活会导致粪卟啉 III 的积累,并导致革兰氏阳性病原体发生光敏化。与光结合使用时,CgoX 的激活可减少 SSTI 小鼠模型中的细菌负担。因此,CgoX 的小分子激活代表了开发基于光的抗菌治疗方法的有效策略。